Genenta Science SPA - ADRGNTA

13F holders, Q1 2024 (March 31)
5holders
$3.66avg. 13F price*

At the end of Q1 2024, 5 institutions reported holding Genenta Science SPA - ADR (GNTA) in their 13F filings. The largest holders were Bank Julius Baer & Co. Ltd, Zurich ($1.4M), Allianz SE ($326K) and Algebris (uk) Ltd. ($146K).

Company
Genenta Science SPA - ADR
CUSIP
36870W100
Latest filing quarter
Q2 2026

History

Number of 13F holders

051015 Q1 2024: 5Q1 2024Q2 2024: 5Q2 2024Q3 2024: 5Q3 2024Q4 2024: 4Q4 2024Q1 2025: 5Q1 2025Q2 2025: 5Q2 2025Q3 2025: 6Q3 2025Q4 2025: 15Q4 2025Q1 2026: 11Q1 2026Q2 2026: 9Q2 2026

Total Exit/New Position Q1 2024

No earlier quarter to compare with.

Ownership 5 holders

Bank Julius Baer & Co. Ltd, Zurich 0.01% Reduce -51.7% 385,313 $1.4M
Allianz SE 0.01% — 93,200 $326K
Algebris (uk) Ltd. 0.06% No change 45,000 $146K
Morgan Stanley 0.00% No change 500 $2K
UBS Group AG 0.00% Reduce -98.2% 41 $144

"% of holder's portfolio" is GNTA's weight in each manager's 13F, not the share of Genenta Science SPA - ADR the manager owns.